Holen Sie sich die Stockscreener-App
14.70
0.07%
-0.01
Handel nachbörslich:
14.70
Edgewise Therapeutics Inc Aktie (EWTX) Neueste Nachrichten
Why Edgewise Therapeutics Inc. is moving todayMarket Activity Report & Low Risk Profit Maximizing Plans - newser.com
What valuation multiples suggest for Edgewise Therapeutics Inc. stockJuly 2025 Institutional & Free Weekly Chart Analysis and Trade Guides - newser.com
What recovery options are there for Edgewise Therapeutics Inc.Quarterly Growth Report & Daily Entry Point Alerts - newser.com
How to build a custom watchlist for Edgewise Therapeutics Inc.Quarterly Profit Report & Real-Time Volume Analysis - newser.com
Key metrics from Edgewise Therapeutics Inc.’s quarterly data2025 Major Catalysts & Growth Focused Entry Reports - newser.com
Edgewise Therapeutics Inc. stock trend forecastIndex Update & Free Growth Oriented Trading Recommendations - newser.com
Building trade automation scripts for Edgewise Therapeutics Inc.July 2025 Trends & AI Powered Buy and Sell Recommendations - newser.com
Is Edgewise Therapeutics Inc. stock supported by innovation pipelineJuly 2025 Pullbacks & Daily Volume Surge Trade Alerts - newser.com
How to use a screener to detect Edgewise Therapeutics Inc. breakoutsMarket Movers & Risk Controlled Stock Alerts - newser.com
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Multi asset correlation models including Edgewise Therapeutics Inc.2025 Analyst Calls & Capital Protection Trading Alerts - newser.com
Can Edgewise Therapeutics Inc. stock beat analyst upgrades2025 Institutional Moves & Weekly Chart Analysis and Guides - newser.com
What analysts say about Edgewise Therapeutics Inc stockMACD Trading Signals & Fast Growing Stocks - earlytimes.in
What drives Edgewise Therapeutics Inc stock priceHigh Frequency Trading Trends & High Return Stock Ideas - earlytimes.in
Edgewise Therapeutics (EWTX): Exploring Valuation After Positive Long-Term Data on Sevasemten in Muscular Dystrophy Trials - Sahm
How high can Edgewise Therapeutics Inc. stock goJuly 2025 Summary & Free Technical Confirmation Trade Alerts - newser.com
Edgewise Therapeutics (NASDAQ:EWTX) Stock Price Down 5.1%Here's What Happened - MarketBeat
Can a trend reversal in Edgewise Therapeutics Inc. lead to recoveryGDP Growth & Safe Entry Trade Reports - newser.com
Applying Elliott Wave Theory to Edgewise Therapeutics Inc.Portfolio Return Report & Technical Entry and Exit Tips - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Edgewise Therapeutics (NASDAQ:EWTX) - MarketBeat
How Investors May Respond To Edgewise Therapeutics (EWTX) Long-Term Sevasemten Data at World Muscle Congress - Yahoo Finance
Edgewise Therapeutics (EWTX): Evaluating Valuation as New Long-Term Clinical Data Sparks Investor Interest - Yahoo Finance
Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring A 135.53% Upside Potential - DirectorsTalk Interviews
How Investors Are Reacting To Edgewise Therapeutics (EWTX) Unveiling Long-Term Data for Sevasemten at WMS 2025 - Sahm
Edgewise Therapeutics presents muscular dystrophy research at Vienna conference - Traders Union
Tools to monitor Edgewise Therapeutics Inc. recovery probabilityWeekly Trend Report & Long-Term Growth Stock Strategies - newser.com
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - Eastern Progress
Edgewise Therapeutics (EWTX): Reviewing Valuation After Recent Momentum Shifts - Sahm
Edgewise Therapeutics, Inc. $EWTX Shares Acquired by HighMark Wealth Management LLC - MarketBeat
Best data tools to analyze Edgewise Therapeutics Inc. stockTrade Entry Report & Smart Money Movement Tracker - newser.com
Will earnings trigger a reversal in Edgewise Therapeutics Inc.Weekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
Edgewise Therapeutics reports inducement grants as permitted by Nasdaq listing rules - MarketScreener
Breakthrough Muscular Dystrophy Treatment: Edgewise's Sevasemten Shows Disease Stabilization in Key Trials - Stock Titan
Wall Street Analysts Think Edgewise Therapeutics (EWTX) Could Surge 182%: Read This Before Placing a Bet - MSN
Is Edgewise Therapeutics Inc a good long term investmentShort-Term Trading Alerts & Set Up Real-Time Alerts – It’s Free - earlytimes.in
Edgewise Therapeutics (NASDAQ:EWTX) Raised to "Hold" at The Goldman Sachs Group - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Trading Down 8.5%Here's Why - MarketBeat
The Goldman Sachs Group Begins Coverage on Edgewise Therapeutics (NASDAQ:EWTX) - MarketBeat
Goldman Sachs Initiates Coverage of Edgewise Therapeutics (EWTX) with Neutral Recommendation - Nasdaq
Goldman Sachs initiates Edgewise Therapeutics stock with Neutral rating By Investing.com - Investing.com Canada
Edgewise Therapeutics (NASDAQ:EWTX) Trading 8.5% HigherShould You Buy? - MarketBeat
Pattern recognition hints at Edgewise Therapeutics Inc. upsideWeekly Volume Report & Capital Protection Trading Alerts - newser.com
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $40.55 Average Price Target from Analysts - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Trading Down 4.8%Should You Sell? - MarketBeat
Full technical analysis of Edgewise Therapeutics Inc. stockAnalyst Upgrade & Risk Adjusted Buy/Sell Alerts - newser.com
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):